Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
3m agoCC Capital and OneIM Complete Acquisition of Insignia Financial Limited, Australia's Leading Diversified Wealth Management Group
35m agoCanadian Gold Resources Strengthens Board with Capital Markets Veteran Kenneth Chernin
35m agoWaraba Gold Signs Binding Agreement to Establish Joint Venture Relating to Tengrela South Exploration Permit Application in Cote d'Ivoire
35m agoSierra Madre Announces Shareholder Approval of Acquisition of Del Toro Silver Mine
36m agoFirst Quantum Minerals Reports First Quarter 2026 Results

Satellos Bioscience Inc.

About

Satellos Bioscience Inc. (TO:MSCL) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 9 2026
Satellos to Present at the Bloom Burton & Co. Healthcare Investor Conference
Mar 27 2026
Satellos Reports 2025 Financial Results and Highlights Recent Company Progress
Mar 10 2026
Satellos Presents Interim SAT-3247 Clinical and Biomarker Data in Duchenne Muscular Dystrophy at the 2026 MDA Clinical & Scientific Conference
Feb 24 2026
Satellos Announces Upcoming Oral and Poster Presentations at the 2026 Muscular Dystrophy Association Clinical & Scientific Conference
Feb 18 2026
Satellos to Host Virtual KOL Event on SAT-3247 in Duchenne Muscular Dystrophy

Financials

Revenue
CA$0
Market Cap
CA$170.17 M
EPS
-28.37

Community Chat

Ask AI

6ix6ix